Skip to main content
Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
62.42
+2.01 (3.33%)
At close: Mar 9, 2026, 4:00 PM EDT
63.14
+0.72 (1.15%)
After-hours: Mar 9, 2026, 5:11 PM EDT

Cytokinetics Revenue

In the year 2025, Cytokinetics had annual revenue of $88.04M with 376.56% growth. Cytokinetics had revenue of $17.76M in the quarter ending December 31, 2025, with 4.89% growth.

Revenue (ttm)
$88.04M
Revenue Growth
+376.56%
P/S Ratio
86.39
Revenue / Employee
$130,816
Employees
673
Market Cap
7.69B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202588.04M69.57M376.56%
Dec 31, 202418.47M10.94M145.34%
Dec 31, 20237.53M-87.06M-92.04%
Dec 31, 202294.59M24.16M34.30%
Dec 31, 202170.43M14.60M26.15%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Halozyme Therapeutics 1.40B
Bio-Techne 1.22B
Arrowhead Pharmaceuticals 1.09B
Axsome Therapeutics 638.50M
Krystal Biotech 389.13M
Kymera Therapeutics 39.21M
Praxis Precision Medicines 7.46M
ABIVAX Société Anonyme 6.23M
Revenue Rankings

CYTK News

More News